DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Joensuu H, Eriksson M, Sundby Hall K et al.
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
JAMA 2012;
307: 1265-1272
We do not assume any responsibility for the contents of the web pages of other providers.